Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

N-Acetyl Cysteine and Reduced Pain Severity

Doses used in studies

mg/day: 1,200 (median 1,200, IQR 1,200–1,200) — 1 study

Time to effect

Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 1 of 1 study

1 of 1 paper

N-Acetyl Cysteine as an Add-on Therapy is Useful in Treating Acute Lumbar Radiculopathy Caused by Disc Herniation: Results of a Randomized, Controlled Clinical Trial.
- 2023-11
- RCT
- Reviews on recent clinical trials 18(4)
- - Bijan Heidari
  - Zeinab-Alsadat Seyedian
  - Maryam Mehrpooya
  - Davoud Ahmadimoghaddam
  - Mahtabalsadat Mirjalili
  - Masood Ghiasian
- PubMed: 37779397
- DOI: 10.2174/0115748871250545230919055109
4 Insights on
- Reduced Pain Severity
- High evidence
- Clinical
A comparison of the VAS ... scores at weeks 2 and 4 of the treatment between the two groups did not show a significant difference
Effect
Neutral
Effect size
Small
Significant
No
Dose
600 mg twice a day